Baotou Dongbao Bio-Tech Co.,Ltd

SZSE:300239 Stock Report

Market Cap: CN¥3.3b

Baotou Dongbao Bio-TechLtd Valuation

Is 300239 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300239 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300239 (CN¥5.58) is trading below our estimate of fair value (CN¥10.89)

Significantly Below Fair Value: 300239 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300239?

Other financial metrics that can be useful for relative valuation.

300239 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.6x
Enterprise Value/EBITDA16.5x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 300239's PE Ratio compare to its peers?

The above table shows the PE ratio for 300239 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average60.5x
688089 Cabio Biotech (Wuhan)
27.4x15.2%CN¥3.4b
688179 Shanghai Aladdin Biochemical TechnologyLtd
36.3x46.6%CN¥3.7b
688133 Shanghai Titan Scientific
126.6x57.5%CN¥3.4b
002054 Dymatic ChemicalsInc
51.7xn/aCN¥2.6b
300239 Baotou Dongbao Bio-TechLtd
31.2xn/aCN¥3.3b

Price-To-Earnings vs Peers: 300239 is good value based on its Price-To-Earnings Ratio (31.2x) compared to the peer average (60.5x).


Price to Earnings Ratio vs Industry

How does 300239's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a33.7%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a33.7%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 300239 is good value based on its Price-To-Earnings Ratio (31.2x) compared to the CN Chemicals industry average (33.6x).


Price to Earnings Ratio vs Fair Ratio

What is 300239's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300239 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio31.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 300239's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies